Cabtreo 1.5 mg/g
clindamycin phosphate/benzoyl peroxide/adapalene · GEL · Bausch Health US LLC
Cabtreo is a gel containing clindamycin phosphate/benzoyl peroxide/adapalene at 1.5 mg/g, taken topical. Manufactured by Bausch Health US LLC.
Key Facts
- Brand Name
- Cabtreo
- Generic Name
- clindamycin phosphate/benzoyl peroxide/adapalene
- NDC Code (Product)
0187-0006- Manufacturer
- Bausch Health US LLC
- Strength
- 1.5 mg/g
- Dosage Form
- GEL
- Route
- TOPICAL
- Marketing Status
- Application #
- NDA216632
- Drug Class
- Retinoid [EPC]
- Marketing Start
- 10/20/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Cabtreo used for?
Cabtreo contains clindamycin phosphate/benzoyl peroxide/adapalene. It is a gel taken topical. Consult your doctor for specific uses.
Is Cabtreo a controlled substance?
Cabtreo is not classified as a controlled substance by the DEA.
What is the generic name for Cabtreo?
The generic name for Cabtreo is clindamycin phosphate/benzoyl peroxide/adapalene. There are no other listed brand versions of clindamycin phosphate/benzoyl peroxide/adapalene.
What is the NDC code for Cabtreo 1.5 mg/g?
The NDC (National Drug Code) for Cabtreo 1.5 mg/g is 0187-0006, listed by Bausch Health US LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)